海外オンラインカジノ、日本からアクセス急増 規制困難

Corporate Corporate Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center  Digital Showroom  Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Products Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investors Investors Management Policy Message from the President --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data ∟Financial Highlight ∟Historical DATA  Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information ∟Stock Information ∟Dividend ∟Shareholders Meeting ∟Articles of Incorporation ∟Ratings and Bonds Sustainability Sustainability Sustainability Activities Sustainability Approach and Promotion Structure Material Issues and　Sustainability(MOS) Indices​ ESG Initiatives Environment Social Governance Sustainability Data Sustainability (MOS) Results Non-Financial Data Sheets GRI Standards Integrated report "KAITEKI Report" News News Releases Information IR News TSE Filings Contact Us 日本語 English 中文 --> --> --> --> HOME Investor Relations TSE Filings TSE Filings 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 and before 2024 May 15, 2024 Consolidated Financial Results for the Fiscal Year Ended March 31, 2024 (Under IFRS) Mar. 12, 2024 Notice Concerning Change of Major Shareholder Feb. 22, 2024 Notice Regarding Change (Appointed) of Representative Corporate Executive Officer Feb. 8, 2024 Notice Regarding Change (Retirement) of Representative Corporate Executive Officer Feb. 6, 2024 Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024 (Under IFRS) 2023 Dec. 22, 2023 Notice Regarding Change in Representative Corporate Executive Officers Dec. 22, 2023 Notice Concerning Change of Specified Subsidiary (Share Transfer) Dec. 5, 2023 Nippon Sanso Holdings Corporation Announces “Notice Regarding Early Redemption of Hybrid Bonds (Public Subordinated Bonds)” Nov. 1, 2023 Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2024 (Under IFRS) Nov. 1, 2023 Notice On Differences between Financial Results Forecast and Financial Results for the First Half of Fiscal 2023, ending March 31, 2024, and Revisions to Annual Forecast Aug. 2, 2023 Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 (Under IFRS) Jun. 30, 2023 Corporate Split in Tandem with Intergroup Organizational Restructuring May 19, 2023 Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2024 May 19, 2023 Notice Regarding Distribution of Dividends from Surplus May 19, 2023 (Updated) Notice Regarding Partial Amendments of “Notice Regarding Distribution of Dividends from Surplus” May 12, 2023 Consolidated Financial Results for the Fiscal Year Ended March 31, 2023 (Under IFRS) Mar. 29, 2023 Notice Concerning Change of Major Shareholder Feb. 24, 2023 Notice regarding Specific Action Plan and Update of Performance Targets related to Management Policy "Forging the future" Feb. 16, 2023 Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023 Feb. 14, 2023 Notice of Award for the Arbitration Filed against Mitsubishi Tanabe Pharma Corporation, a Consolidated Subsidiary Feb. 7, 2023 Notice on Absorption-type Merger of a Wholly-owned Subsidiary (Simplified Merger and Short-form Merger) Feb. 7, 2023 Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023 Feb. 7, 2023 Earnings Impact due to Cessation of MMA-related Product Production at Mitsubishi Chemical UK Limited and Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023 Jan. 20, 2023 Notice Regarding Changes in Representative Corporate Executive Officer 2022 Dec. 20, 2022 Notice on Cessation of the Production of Methacrylates in Mitsubishi Chemical UK Limited Nov. 24, 2022 Notice on the Start of Consultation on Cessation of the Production of Methacrylates in Mitsubishi Chemical UK Limited Nov. 8, 2022 Notice On Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023 Nov. 8, 2022 Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2023 (Under IFRS) Aug. 22, 2022 Corporate Split in Tandem with Intergroup Organizational Restructuring Aug. 3, 2022 Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023 (Under IFRS) Aug. 2, 2022 Regarding Some News Reports Today May 19, 2022 Notice on Change of Trade Name and Partial Amendment to Articles of Incorporation May 19, 2022 Notice Regarding Distribution of Dividends from Surplus May 19, 2022 Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2024 May 13, 2022 Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 (Under IFRS) Apr. 27, 2022 Notice Regarding Disposition of Treasury Shares as Equity Compensation in the Form of Restricted Shares Mar. 31, 2022 Notice on Absorption-type Merger of a Wholly-owned Subsidiary (Simplified Merger and Short-form Merger) Feb. 3, 2022 Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022 (Under IFRS) Jan. 7, 2022 Notice Regarding Changes in Representative Corporate Executive Officers 2021 Dec. 1, 2021 Formulation of New Management Policy “Forging the future” Nov. 26, 2021 Notice of Changes Regarding the Corporate Executive Officer and Chief Financial Officer Nov. 2, 2021 Notice of Revision to Consolidated Financial Results Forecast, Distribution of Dividend (Interim Dividend) of Surplus, and Revision to Year-end Dividend Forecast for the Fiscal Year Ending March 31, 2022 Nov. 2, 2021 Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2022 (Under IFRS) Sep. 30, 2021 Notice on Company Split (Simplified Absorption-type Company Split) and Share Transfer in Line with Transfer of the Polycrystalline Alumina Fiber Business of the Consolidated Subsidiary (Mitsubishi Chemical Corporation) Aug. 4, 2021 Notice Regarding Revision to Consolidated Financial Results Forecast for the First Half of Fiscal Year Ending March 31, 2022 Aug. 4, 2021 Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 (Under IFRS) Jul. 12, 2021 Notice on Continuation of Performance-based Share Compensation Program Which Uses a Trust May 19, 2021 Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2022 and Zero Coupon Convertible Bonds due 2024 May 19, 2021 Notice Regarding Distribution of Dividends from Surplus May 12, 2021 Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 (Under IFRS) May 12, 2021 Notice Regarding Differences between Financial Results Forecast and Financial Results for the Fiscal Year Ended March 31, 2021 Apr. 28, 2021 Notice Regarding Disposition of Treasury Shares as Equity Compensation in the Form of Restricted Shares and Introduction of Performance-Linked Equity Compensation (Performance Share Unit) Scheme Feb. 25, 2021 Formulation of New Medium-Term Management Plan APTSIS 25 Step 1 Feb. 25, 2021 Notice Regarding Changes in Representative Corporate Executive Officers Feb. 3, 2021 Condensed Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2021 Feb. 3, 2021 Notice Regarding Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2021 2020 Nov. 4, 2020 Condensed Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2021 Nov. 4, 2020 Mitsubishi Chemical to End MMA Monomer and MAA Production in Texas and Close Site Nov. 4, 2020 Notice Regarding the Recording of Impairment Loss Nov. 4, 2020 Notice Regarding Differences between Financial Results Forecast andFinancial Results for the First Half of Fiscal 2020, and Revisions to Annual Forecast Oct. 23, 2020 Notice Regarding Change in Representative Corporate Executive Officers Aug. 4, 2020 Condensed Consolidated Financial Information for the First Quarter of the Fiscal Year Ending March 31, 2021 May 26, 2020 Announcement Regarding Adjustment of Conversion Price forZero Coupon Convertible Bonds due 2022 andZero Coupon Convertible Bonds due 2024 May 26, 2020 Notice Regarding Distribution of Dividends from Surplus May 26, 2020 Notice Regarding Disposition of Treasury Shares as Equity Compensation in theForm of Restricted Shares May 15, 2020 Taiyo Nippon Sanso Corporation AnnouncesNotice of Absorption-Type Company Split Agreement for Transition to a Holding Company Structure Through Company Split and Partial Amendments to Articles of Incorporation (Tradename and Business Purpose) May 13, 2020 Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2020 Apr. 28, 2020 Notice of Revision to Consolidated Financial Results Forecast and Dividends Forecast for the Fiscal Year Ended March 31, 2020 Feb. 6, 2020 Notice on Revision to Consolidated Financial Results Forecastfor the Fiscal Year Ending March 31, 2020 Feb. 6, 2020 Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2020 Jan. 22, 2020 Taiyo Nippon Sanso Corporation Announces “Notice of Transition to a Holding Company Structure Through Company Split, Incorporation of a Subsidiary (Company-Split Preparation Company), and Partial Amendment to the Articles of Incorporation (Tradename Change)” Jan. 8, 2020 Announcement in Relation to Results of Tender Offer for Shares of Mitsubishi Tanabe Pharma Corporation (Securities Code: 4508) 2019 Nov. 18, 2019 Announcement of Commencement of Tender Offer for Shares of Mitsubishi Tanabe Pharma Corporation (Securities Code: 4508) Nov. 1, 2019 Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2020 Nov. 1, 2019 Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2020 Jul. 30, 2019 Consolidated Financial Information for the First Quarter of the Fiscal Year Ending March 31, 2020 May 22, 2019 Notice Regarding Distribution of Dividends from Surplus May 22, 2019 Announcement Regarding Adjustment of Conversion Price forZero Coupon Convertible Bonds due 2022 andZero Coupon Convertible Bonds due 2024 May 14, 2019 Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2019 Mar. 18, 2019 Taiyo Nippon Sanso Corporation Announces“Notice Regarding Financing through a Subordinated Loan” Mar. 1, 2019 Notice Regarding Completed Acquisition of a HyCO Business and Related Assetsin the United States Feb. 25, 2019 Notice Regarding Changes in Representative Corporate Executive Officers Feb. 20, 2019 Mitsubishi Tanabe Pharma Corporation Received Notice of Request for Arbitration Feb. 6, 2019 Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2019 Jan. 22, 2019 Taiyo Nippon Sanso Corporation Announces“Notice Regarding Determination of Issuance Conditions for Hybrid Bonds(Public Subordinated Bonds)” 2018 Dec. 13, 2018 Taiyo Nippon Sanso Corporation Announces “Notice Regarding Acquisition ofa HyCO Business and Related Assets in the United States” Dec. 4, 2018 Revision of Targets under Medium-Term Management Plan APTSIS20 Dec. 4, 2018 Taiyo Nippon Sanso Corporation Announces “Notice Regarding Issue of Hybrid Bonds (Public Subordinated Bonds)” Dec. 3, 2018 Taiyo Nippon Sanso Corporation Announces“Notice Regarding Completed Acquisition (100% Ownership) Procedures of US Company Praxair, Inc.’s European Businesses” Nov. 27, 2018 Taiyo Nippon Sanso Corporation Announces Notice of Conclusion of Bridge Loan Agreement Concerning Acquisition (100% Ownership) of US Company, Praxair, Inc.’s European Businesses Nov. 26, 2018 Notice Regarding Changes in Specified Subsidiaries Nov. 1, 2018 Revision of Forecasts for Consolidated Financial Results and Dividends for Fiscal Year Ending March 31, 2019 Nov. 1, 2018 Notice Regarding Distribution of Dividends from Surplus (Interim Dividend) Nov. 1, 2018 Notice Regarding Differences between Consolidated Financial Results Forecast and Financial Results for the First Half of the Fiscal Year Ending March 31, 2019 Nov. 1, 2018 Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2019 Aug. 29, 2018 Notice Regarding Disposition of Treasury Shares through Third-party Allotment Associated with Introduction of New Performance-based Share Compensation Plan Jul. 31, 2018 Consolidated Financial Information for the First Quarter of the Fiscal Year Ending March 31, 2019 Jul. 24, 2018 Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Corporate Executive Officers Jul. 10, 2018 (Updated)Partial Revision to the “Notice of Acquisition (100% Ownership) of US Company,Praxair, Inc.’s European Businesses” Jul. 9, 2018 Announcement Regarding the Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Corporate Executive Officers Jul. 9, 2018 Announcement Regarding the Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Executive Officers, etc. Jul. 5, 2018 Notice of Acquisition (100% Ownership) of US Company, Praxair, Inc.’s European Businesses Jun. 26, 2018 Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2022 and Zero Coupon Convertible Bonds due 2024 Jun. 6, 2018 Notice on Introduction of New Performance-based Share Compensation Plan Jun. 4, 2018 Notice Regarding Result and Completion of Acquisition of Treasury Stock May 16, 2018 Notice Regarding Distribution of Dividends from Surplus May 11, 2018 Notice Regarding Result of Acquisition of Treasury Stock through Off-Auction Own Shares Repurchase Trading System (ToSTNeT-3) May 10, 2018 Notice Regarding Acquisition of Treasury Stock and Share Buyback through Off-Auction Own Shares Repurchase Trading System (ToSTNeT-3) May 10, 2018 Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2018 May 10, 2018 Announcement on Determination of Acquisition Price through Off-Auction Own Shares Repurchase Trading System (ToSTNeT-3) May 10, 2018 Notice Regarding Revision to Dividend Forecast for the Fiscal Year Ended March 31, 2018 Apr. 4, 2018 Mitsubishi Chemical Announces MMA Monomer and PMMA Plants Start Commercial Operations in Saudi Arabia Feb. 26, 2018 Notice Regarding Changes in Representative Corporate Executive Officers and Corporate Executive Officer Feb. 6, 2018 Revision to Consolidated Financial Results Forecast for Fiscal Year Ending March 31, 2018 Feb. 6, 2018 Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2018 2017 Dec. 22, 2017 Notice Regarding Change in Representative Directors at Consolidated Subsidiary (Mitsubishi Chemical Corporation) Nov. 2, 2017 Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2018 Nov. 2, 2017 Notice Concerning Sale of Shares Held by Untraceable Shareholders Oct. 26, 2017 Revision of Forecasts for Consolidated Financial Results and Dividends for Fiscal Year Ending March 31, 2018 Aug. 1, 2017 Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2018 Jul. 25, 2017 Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to corporate executive officers Jul. 24, 2017 Mitsubishi Tanabe Pharma to Acquire NeuroDerm Ltd. Jul. 10, 2017 Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Corporate Executive Officers Jul. 10, 2017 Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Executive Officers, etc. May 19, 2017 Announcement of Additional Disclosure of “Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2017 Announced on May 12, 2017 May 17, 2017 Notice Regarding Distribution of Dividends from Surplus May 12, 2017 Financial Results Announcement for the Fiscal Year Ended March 31, 2017 May 12, 2017 Notice Regarding Revision to Dividend Forecast for the Fiscal Year Ended March 31, 2017 Mar. 15, 2017 Announcement Regarding Result and Completion of Repurchase of Treasury Stockthrough Off-Auction Treasury Stock Repurchase Trading System (ToSTNeT-3) Mar. 14, 2017 Announcement Regarding the Issuance of Zero Coupon Convertible Bonds due 2022and Zero Coupon Convertible Bonds due 2024 Mar. 14, 2017 Announcement Regarding Repurchase of Treasury Stock Feb. 8, 2017 Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2017 Feb. 8, 2017 Revision of Forecasts for Consolidated Financial Results and Dividendsfor Fiscal Year Ending March 31, 2017 2016 Dec. 22, 2016 Notice Regarding a Corporate Split-Off Nov. 30, 2016 Announcement Regarding Disposition of Treasury Sharesvia Allotment to Subsidiary Nov. 8, 2016 Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2017 Oct. 28, 2016 Revision to First Half and Full Year Consolidated Financial Results Forecastsfor Fiscal Year Ending March 31, 2017 Sep. 14, 2016 Announcement regarding the Conversion of Nippon Kasei Chemicalby means of the Share Exchange into a Wholly-Owned Subsidiary of Mitsubishi Chemical Corporation Sep. 5, 2016 Notice Regarding Change in Trade Name of Consolidated Subsidiary Aug. 5, 2016 Announcement of Commencement of Tender Offer for Shares of The Nippon Synthetic Chemical Industry Co., Ltd. by Our Consolidated Subsidiaries Aug. 5, 2016 Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2017 Jul. 27, 2016 Notice Regarding Reorganization of Purified Terephtharic Acid Businessin India and China Jul. 19, 2016 Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Directors Jul. 1, 2016 Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Executive Officers, etc. Jul. 1, 2016 Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Corporate Executive Officers Jun. 24, 2016 Notice Regarding Top Executives and Management Structure of New Integrated Company May 18, 2016 Notice Regarding Distribution of Dividends from Surplus May 13, 2016 Notice Regarding Revision to Dividend Forecast for the Fiscal Year Ended March 31, 2016 May 13, 2016 Financial Results Announcement for the Fiscal Year Ended March 31, 2016 Mar. 9, 2016 Top Executives Named for Newly FormedAsahi Kasei Mitsubishi Chemical Ethylene Corporation Mar. 4, 2016 Notice Regarding Trade Name of New Integrated Company Feb. 24, 2016 Notice Regarding a Corporate Split-Off (Simplified/Abbreviated Split-Off) Feb. 4, 2016 Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2016 Feb. 4, 2016 Recognition of Impairment Loss and Revision to Consolidated Financial Results Forecastsfor the Fiscal Year Ending March 31, 2016 2015 Dec. 9, 2015 Formulation of APTSIS 20 New Medium-Term Management Plan Dec. 9, 2015 Notice Regarding Integration of Three Consolidated Subsidiaries Nov. 5, 2015 Revision to Consolidated Financial Results Forecasts for the Fiscal Year Ending March 31, 2016 Nov. 5, 2015 Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2016 Sep. 28, 2015 Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Directors Sep. 11, 2015 Announcement Regarding the Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Executive Officers, etc. Sep. 11, 2015 Amendment to "Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Directors" Sep. 11, 2015 Announcement Regarding the Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Directors Aug. 5, 2015 Revision to Consolidated Financial Results Forecasts for the First Half of Fiscal Year Ending March 31, 2016 Aug. 5, 2015 Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2016 Jul. 16, 2015 Mitsubishi Chemical Holdings Group Begins Study of Organizational Restructuringwith an Eye toward Integration of Chemical Operating Companies May 28, 2015 Establishment of a Joint Venture for Operation of Unified Naphtha Cracker in Mizushima May 13, 2015 Partial Amendment to the Articles of Incorporation May 13, 2015 Financial Results Announcement for the Fiscal Year Ended March 31, 2015 May 1, 2015 Revision of Forecasts for Consolidated Financial Results and Dividends for the Fiscal Year Ending March 31, 2015 May 1, 2015 Announcement Regarding Changes in Representative Corporate Executive Officers Feb. 26, 2015 Notice Regarding Change in Representative Directors Feb. 5, 2015 (Corrections) Notice on Acquisition of Treasury Stock from a Subsidiary -Acquisition of Treasury Stock Pursuant to Article 163 of the Companies Act- Feb. 4, 2015 Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2015 Feb. 4, 2015 Notice on Acquisition of Treasury Stock from a Subsidiary 2014 Dec. 25, 2014 Announcement Regarding Executive Personnel Changes and Transfer to a Company with Committees Nov. 27, 2014 Revision to Consolidated Financial Results Forecasts for the Fiscal Year Ending March 31, 2015 Nov. 6, 2014 Announcement of Results of Tender Offer for Shares of Taiyo Nippon Sanso Corporation (TSE Code: 4091) and Change in Subsidiary Oct. 31, 2014 Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2015 Oct. 22, 2014 Revision to the Consolidated Financial Results Forecasts for the First Half of Fiscal Year Ending March 31, 2015 Oct. 21, 2014 Mitsubishi Tanabe Pharma Announces a Revision to the Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2015 Sep. 29, 2014 Announcement of Commencement of Tender Offer for Shares of Taiyo Nippon Sanso Corporation (TSE Code: 4091) Aug. 1, 2014 Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2015 Jun. 26, 2014 Mitsubishi Rayon Announces Establishment of MMA Monomer/PMMA Joint Venture in Saudi Arabia, and Order for Plant Construction May 30, 2014 Notice Regarding Voluntary Adoption of International Financial Reporting Standards (IFRS) May 13, 2014 Notice Regarding Execution of an Agreement in connection with Tender Offer by Mitsubishi Chemical Holdings Corporation for Shares of Taiyo Nippon Sanso Corporation May 12, 2014 Financial Results Announcement for the Fiscal Year Ended March 31, 2014 Feb. 25, 2014 Changes in Representative Directors Feb. 6, 2014 Mitsubishi Chemical Holdings to Establish Life Science Institute, Inc. Feb. 5, 2014 Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2014 Feb. 5, 2014 Revision to Consolidated Financial Results Forecasts for Fiscal Year Ending March 31, 2014 2013 and before Oct. 31, 2013 Revision to Consolidated Financial Results Forecasts for Fiscal Year Ending March 31, 2014 Oct. 31, 2013 Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2014 Oct. 22, 2013 Revision to the Consolidated Financial Results Forecasts for the Fist Half of Fiscal Year Ending March 31, 2014 Sep. 30, 2013 Mitsubishi Tanabe Pharma Announces Notice Regarding Administrative Action Related to Violation of Pharmaceutical Affairs Law of Japan Sep. 26, 2013 Notice of change in the number of shares constituting one unit and amendment to the Articles of Incorporation Sep. 26, 2013 Notice regarding the Capital and Business Alliance between Mitsubishi Chemical Group Corporation and Taiyo Nippon Sanso Corporation Sep. 25, 2013 Mitsubishi Tanabe Pharma Announces a Revision to 2Q Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2014 Sep. 19, 2013 Notice Regarding Completion of Acquisition of Shares of Medicago, lnc., a Pharmaceutical Company Based in Canada, Which Has Become a Subsidiary of Mitsubishi Tanabe Pharma Aug. 02, 2013 Progress in study for unification of naphtha cracker facilities in Mizushima Aug. 01, 2013 Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2014 Jul. 12, 2013 Notice Regarding the Acquisition of Medicago Inc. May 09, 2013 Financial Results Announcement for the Fiscal Year Ended March 31, 2013 Mar. 05, 2013 Announcement Regarding the Medium-term Management Plan, APTSIS 15 Mar. 01, 2013 Completion of Acquisition of the Qualicaps Co., Ltd. Feb. 20, 2013 Revision to Consolidated Financial Results Forecasts for the Fiscal Year Ending March 31, 2013 Feb. 05, 2013 Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2013 Corporate Information Corporate Information Corporate Information Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center Digital Showroom Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Business・Products Business・Products Innovation Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investor Relations Investor Relations Investor Relations Management Policy Message from the President --> Message from the CFO --> Outside Directors’ Discussion Meeting --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information Sustainability Sustainability Sustainability Sustainability Activities Sustainability approach and promotion structure Material Issues and Sustainability(MOS) Indices ESG Initiatives Environment Society Governance Sustainability Data Sustainability (MOS) results Non-Financial Data Sheets GRI Standards KAITEKI Solution Center News Releases Information Digital Showroom Contact Us FAQ The Mitsubishi Chemical Group Official Accounts Sitemap Terms of Use Privacy Policy Social Media Terms of Use Copyright © Mitsubishi Chemical Group Corporation.